On June 24, 2022 Svenja Vishnolia has very successfully defended her MD thesis “Allele-specific RNA-targeted therapy as a treatment strategy for Col6-CMD”. Svenja is the first to complete her doctoral thesis on Collagen-6. She did a fantastic job.
It was a wonderful talk and an impressive Q&A session. Congratulations!